We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.
We offer clients exceptional insight in dealing with competition agencies in the United States, Europe and around the world.
“The firm is at its best during a fight—whether that’s against an enforcer, or in court against a private litigant.” — Global Competition Review
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their business possible. Our attorneys excel at brokering material transfer agreements, manufacturing and supply agreements, confidentiality agreements and distribution agreements. They also frequently represent biotech venture capital clients as they license patents—the foundations of their companies—from leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances and successfully navigate a complex, dynamic industry.
When legal, public policy and media challenges converge and an institution's reputation and business are at stake, no firm rivals WilmerHale’s ability to navigate fast-moving events and craft lasting solutions.
WilmerHale’s corporate lawyers have a long history of experience with cross-border deals involving mergers and acquisitions, public offerings and capital markets, venture capital, joint ventures and other transactions.